SCN5A Variant N826D

Summary of observed carriers, functional annotations, and structural context for SCN5A N826D. Data combine curated literature, international cohorts, and gnomAD observations.

Estimated LQT3 penetrance

8%

0/11 effective observations

Estimated BrS1 penetrance

10%

1/11 effective observations

Total carriers

1

0 BrS1 · 0 LQT3 · 1 unaffected

N826D is present in 1 alleles in gnomAD. This residue resides in a Non_Hotspot region for Brugada syndrome and a Mild_Hotspot region for LQT3.

Variant features alone are equivalent to phenotyping 1 individuals for Brugada syndrome and 0 individuals for LQT3.

In silico predictors

Variant-level computational predictors.
PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
-4.95 0.993 -3.08 0.877 5 11

PROVEAN scores below -2 suggest deleterious impact. REVEL scores above 0.5–0.75 are often interpreted as likely pathogenic. PolyPhen-2 scores above 0.85 are typically pathogenic. Penetrance density summarises neighbouring residue risk (Kroncke et al. 2019).

Reported carrier data

Observed carriers by publication or cohort.
Source Year Carriers Unaffected LQT3 BrS1 Other Other Disease
Literature, cohort, and gnomAD 1 1 0 0
Variant features alone 15 14 0 1

Totals may differ from individual publications due to duplicate patients removed during curation.

Nearby variants

Neighbouring residues within 15 Ångström provide structural context. Variants listed in the right-most column have been observed clinically or in gnomAD.

Previously observed variants near N826D.
Neighbour residue Distance (Å) Observed variants
821 8
1340 11 V1340I,
1339 12 L1339F, p.L1339del
780 13
1344 13 F1344S, F1344L,
819 5
826 0 N826D,
818 10
825 5
781 9 W781X,
720 15
822 8 W822X, W822C,
944 14
830 7
833 11 G833R,
724 14 T724I,
782 15 N782T,
831 10
820 7
823 5 P823T,
942 14
834 12 N834D,
827 5
816 11 F816L, F816Y,
817 11 K817E,
779 14 Q779X, Q779K,
815 13
1343 13
1337 14
784 13 F784L,
1336 13
824 6
829 6
832 11
835 15 S835A, S835L,
828 7 L828V,